Home › Ductal Carcinoma In Situ (DCIS) › NCT02918474
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Recruiting
Decision Making Tool for Contralateral Prophylactic Mastectomy
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Newly diagnosed ductal breast carcinoma in situ (DCIS) or stage I-III sporadic unilateral invasive breast cancer * Able to speak read or write English Exclusion Criteria: * Patients with previous breast cancer * Prior history of bilateral prophylactic mastectomy * Known to have a germline mutation that predisposes them to an increased risk of breast cancer (e.g. BRCA1/2) and/or they are considered at high risk for contralateral breast cancer on the basis of a strong family history of cancer
About the study
This trial studies the acceptability and how well decision making tool works in supporting decision making in contralateral prophylactic mastectomy in patients with newly diagnosed breast cancer. Decision making tool may help patients with early stage breast cancer make decisions regarding their surgical options.
What is being tested
- Decision Aid (other)
- Questionnaire Administration (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 15 · Started: Apr 28, 2017
Contact the study team
- Abenaa M Brewster · Phone: 713-745-4949
Official record on ClinicalTrials.gov — NCT02918474
Locations in the U.S.
| Texas | M D Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.